OrsoBio
Natalie Sroda is a Senior Scientist at OrsoBio since October 2022, following a progression of roles in the biotechnology and pharmaceutical industries. Prior experience includes positions at Gilead Sciences as an Associate Scientist and Senior Research Associate II from January 2020 to October 2022, and a contracting role at Integrated Resources, Inc. in late 2019. Earlier, Natalie served as a Senior Research Associate and Research Associate III at Dragonfly Therapeutics, Inc. from January 2018 to July 2019, and worked at Boston Biomedical from October 2015 to January 2018 as Assistant Manager of Preclinical Development & Pharmacology and a Research Associate. Academic qualifications include a Master’s Degree in Pharmacology from Massachusetts College of Pharmacy and Health Sciences and a Bachelor’s Degree in Biochemistry from the University of New England.
This person is not in any teams
OrsoBio
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.